Navigation Links
Trust for America's Health on New HHS Influenza Pandemic Draft Guidance
Date:6/4/2008

TFAH Calls on the Federal Government to Ensure Equitable Protections for All Americans and Their Families

WASHINGTON, June 4 /PRNewswire-USNewswire/ -- Trust for America's Health (TFAH) issued the following statement on the release of The U.S. Department of Health and Human Services(HHS) Draft Guidances to Assist in Preparation for an Influenza Pandemic (http://aspe.hhs.gov/panflu/antiviral-n-masks.shtml) today, emphasizing that the federal government must do all it can to ensure it protects every American from a potential pandemic flu outbreak, especially those who are employed by smaller businesses that may not have the ability or resources to fully prepare.

"Asking employers and families to take tangible steps to prepare in advance for a pandemic influenza outbreak is a step in the right direction. However, the federal government must assure that all Americans have access to the protections HHS recommends," said Jeff Levi, Director of the Trust for America's Health. "An employee of a small to mid-size company should not be penalized because the enterprise can not afford the costs of acquiring, storing and dispensing antiviral medications during a flu pandemic.

"Nor is it reasonable for every American family to stockpile the recommended 20 respirator masks per household or the up to 100 facemasks per family at a cost of $35.00 - $70.00. Even for the families that can afford to stockpile masks, children would likely be left unprotected. There is still no Federal Drug Administration-approved respirator mask for kids, despite the warning by the Centers for Disease Control and Prevention that children can be more susceptible than adults to infection, and compared to adults, children usually shed more influenza virus for a longer period of time.

"In the event of a pandemic outbreak, leaving the massive costs and logistical responsibilities to businesses and
'/>"/>

SOURCE Trust for America's Health
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. BancTec and Enterprise Bank & Trust Partner to Deliver Revenue Cycle Management for Healthcare Providers
2. Antitrust Waiting Period Expires on Allscripts-Misys Merger Agreement
3. Mutual Protection Trust Earns Third A+ Rating From A.M. Best
4. MedTrust Online Collaborates With Oracle and Dell to Provide Oncologists With the Next Generation Tool for Personalized Care Delivery
5. When your memories can no longer be trusted
6. Alsius Corporation Awarded Three-Year Agreement with HealthTrust Purchasing Group
7. ABMS Assembly Votes in Favor of Three-Year Initiative to Enhance Public Trust in the Board Certification Process
8. Healthcare Realty Trust Announces First Quarter Results
9. BioMed Realty Trust Reports First Quarter 2008 Financial Results
10. Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes
11. Universal Health Realty Income Trust Reports 2008 First Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...ption leads to success, study finds , ,...rcise, reduced soda consumption and self-weighing ...gies for adolescents, a new study shows. , Rese...t-control strategies and lifestyle habits. Sixty-t...The responses were grouped into four categories: ,...
(Date:12/4/2009)...patient groups , , FRIDAY, Dec. 4 (Healt... Ewing sarcomas and central nervous system tumors,...rs have found. , The study authors analyzed dat...on pediatric cancers who were enrolled in the Chil...found that the overall cancer recurrence rate was ...
(Date:12/4/2009)... to take breast cancer drug, study finds , ...out side effects are a major reason why only 6 per...cer are willing to take the drug tamoxifen to prev...ort to inform women about the risks and benefits o...igan Comprehensive Cancer Center created a decisio...
(Date:12/4/2009)...4 Today, seven of Florida,s top no...ng the health of Florida,s uninsured and underserv...2009 Sapphire Award ceremony. ,, The Sapphire A...izes and promotes organizations that have demonstr...ithin their communities. ,, Honorees of The 200...
(Date:12/4/2009)...re-FirstCall/ -- Movado Group Inc. (NYSE: MOV ),...a, Georgia, shared in a tribute on December 3, 200...ie Oudin for her stellar performance in the tourna...finalist at the Open since 1999. ,, (Photo: ...84 ) ,, At a celebratory reception held at Brow...
Breaking Medicine News(10 mins):Health News:Teens Lose More Weight Using Healthy Strategies 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2Health News:Top Nonprofits Honored for Improving Health of Floridians 2Health News:Top Nonprofits Honored for Improving Health of Floridians 3
... May 20, 2009Physicians can and should play a lead...g towards comprehensive reform of the way health c...uaranteed 1.5 percent annual savings in health car...chieving Health Care ReformHow Physicians Can Help...
...al communities in California,s Central Valley , ,...re, one of the nation,s first and leading provider...of nephrology research, today announced their part...e Park in the City of Stockton. Satellite Healthca...
...ostatic intraepithelial neoplasia (HGPIN) carries ...ostate cancer. Research published in the open acce...atients whose extended core biopsy led to an initi...dation Trust and Lancaster University, along with ...
...hareholders to Support the Company,s Twelve Nomine..., Inc. (Nasdaq: AMLN ) today reminded its shareh...l of Amylin,s nominees, including its two new inde...bourne Capital Management, L.L.C. , , Amylin,s 20...
...., May 26 Cogdell Spencer Inc. (NYSE: CSA ) ann...lic offering of 18,000,000 shares of common stock....ters an option to purchase up to an additional 2,7...eds from the offering to fund a $50 million repaym...
...6 , , About Dr. Harold Kohn & Vimpat , A...l compound that affects neurological systems, Haro...hapel Hill , inventor of the recently FDA-approved... of perseverance, and Veronica was thrilled to tha...
Other Medicine News:Health News:Physicians can lead health care reform through payment and delivery system reforms 2Health News:Satellite Healthcare Walks for Kidney Health 2Health News:Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today 2Health News:Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today 3Health News:Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today 4Health News:Cogdell Spencer Announces Commencement of Common Stock Offering 2Health News:Cogdell Spencer Announces Commencement of Common Stock Offering 3Health News:Inventor of Newly Available Vimpat(R) (lacosamide) C-V Meets a Woman Who Experienced Greater Seizure Control With Use of This New Antiepileptic Drug 2Health News:Inventor of Newly Available Vimpat(R) (lacosamide) C-V Meets a Woman Who Experienced Greater Seizure Control With Use of This New Antiepileptic Drug 3
(Date:12/4/2009)... 4 Chemistry World re... Pharmaceutical Research and Manufacturers of Ame...accines in development for HIV/AIDS and related co...products in development include 23 vaccines and 54...cal trials or awaiting approval by the U.S. Food a...
(Date:12/4/2009)...wire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: ...ntermeasures against biological and chemical threa... results of a study demonstrating the effectivenes... in the New Zealand White (NZW) rabbit. The data ...HHS Public Health Emergency Medical Countermeasure...
(Date:12/4/2009)...4 OrthoAccel Technologies, Inc., d...acceleration device to enhance orthodontics, annou...n course published by PennWell Corporation , a le..., including medicine and dentistry. The course fo..., a summary of treatment biomechanics, factors tha...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4DURECT Corporation to Participate in Upcoming Healthcare Conferences 57474 1DURECT Corporation to Participate in Upcoming Healthcare Conferences 57474 2National Survey Reveals Healthcare Providers Technological Readiness to Participate in Electronic Health Records Network 57469 1National Survey Reveals Healthcare Providers Technological Readiness to Participate in Electronic Health Records Network 57469 2National Survey Reveals Healthcare Providers Technological Readiness to Participate in Electronic Health Records Network 57469 3YM BIOSCIENCES REPORTS NIMOTUZUMAB APPROVED FOR MARKETING IN MEXICO 14116 1YM BIOSCIENCES REPORTS NIMOTUZUMAB APPROVED FOR MARKETING IN MEXICO 14116 2YM BIOSCIENCES REPORTS NIMOTUZUMAB APPROVED FOR MARKETING IN MEXICO 14116 3YM BIOSCIENCES REPORTS NIMOTUZUMAB APPROVED FOR MARKETING IN MEXICO 14116 4
... a First-in-Class Biologic Treatment Option Now Av...s with JIA(1,2) -, PRINCETON, N.J., April 8, 2008... announced that the U.S. Food and Drug,Administrat...reducing signs,and symptoms in pediatric patients ...tive polyarticular juvenile idiopathic arthritis (...
...d., April 8, 2008 ImQuest scientists Robert,W. Bu...nted the results of,studies performed with product...ecent Microbicides 2008, an international conferen...icide scientists, developers, and care,givers from...ak by the,Conference organizers, presenting the re...
Other Medicine Technology:U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 2U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 3U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 4U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 5U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 6U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 7U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 8U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 9U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older 10ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India 2
Goat Anti-Human IgA, alpha chain Antibody, Colloidal Gold Conjugated, 50 OD
Protein A 50 OD, Colloidal Gold Conjugated/Tagged
Protein A, Gold Ribbon - .25 OD per sq. cm.
Protein G, Gold Ribbon - .50 OD per sq. cm.
Medicine Products: